Michael A. DesJardin - 02 Mar 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role: EVP, Technical Operations
Signature: /s/ Patrick McIlvenny, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 02 Mar 2023
Net transactions value: +$66,953
Form type: 4
Filing time: 06 Mar 2023, 15:48:47 UTC
Previous filing: 06 Jan 2023
Next filing: 06 Oct 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise	$54,181	+3,629	+3%	$14.93^*	125,815	02 Mar 2023	Direct
transaction	HZNP	Ordinary Shares	Options Exercise	$12,772	+743	+0.59%	$17.19^*	126,558	02 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Stock Option (Right to Buy)	Options Exercise	$0	-3,629	-100%	$0.000000^*	0	02 Mar 2023	Ordinary Shares	3,629	$14.93	Direct	F1
transaction	HZNP	Stock Option (Right to Buy)	Options Exercise	$0	-743	-100%	$0.000000^*	0	02 Mar 2023	Ordinary Shares	743	$17.19	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option is fully vested.